ascrinvacumab 0
brazikumab 0
durvalumab 0
elgemtumab 0
farletuzumab 0
fibatuzumab 0
gantenerumab 0
ifabotuzumab 0
ipilimumab 0
pamrevlumab 0
sifalimumab 0
tabalumab 0
vedolizumab 0
veltuzumab 0
